Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | Results of a pooled meta-analysis of factor XIa inhibitors for secondary stroke prevention

Aristeidis Katsanos, MD, PhD, McMaster University, Hamilton, Canada, discusses the results of a meta-analysis of factor XIa inhibitors after noncardioembolic stroke, which showed a consistent effect size in reducing the risk of recurrent ischemic stroke without increasing the risk of hemorrhages. Dr Katsanos highlights that these agents may change stroke prevention strategies and provide a new tool to reduce the risk of stroke recurrence without increasing hemorrhagic risk. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

So we did this pooled meta-analysis of the factor XI studies in secondary stroke prevention that have been completed to date with the OCEANIC-STROKE of course being the biggest one. But we’re happy to see that there was a consistent effect size in the risk reduction of stroke and no increase in hemorrhages including major hemorrhages but even minor hemorrhages. So those agents hopefully we’re going to change our stroke prevention strategies and they’re going to give us a new tool to reduce the risk of stroke recurrence without increasing the hemorrhagic risk of patients after a stroke...

So we did this pooled meta-analysis of the factor XI studies in secondary stroke prevention that have been completed to date with the OCEANIC-STROKE of course being the biggest one. But we’re happy to see that there was a consistent effect size in the risk reduction of stroke and no increase in hemorrhages including major hemorrhages but even minor hemorrhages. So those agents hopefully we’re going to change our stroke prevention strategies and they’re going to give us a new tool to reduce the risk of stroke recurrence without increasing the hemorrhagic risk of patients after a stroke.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.